VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (0)
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
HAWK, ERNEST
One or more keywords matched the following items that are connected to
HAWK, ERNEST
Item Type
Name
Concept
Adenomatous Polyps
Concept
Colonic Polyps
Concept
Intestinal Polyps
Academic Article
A randomised, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis.
Academic Article
NSAID trials, sporadic adenomas, and conservative inferences.
Academic Article
Colorectal cancer prevention.
Academic Article
The adenoma prevention with celecoxib and prevention of colorectal sporadic adenomatous polyps trials: stepping stones to progress.
Academic Article
Sulindac sulfone induced regression of rectal polyps in patients with familial adenomatous polyposis.
Academic Article
Ursodeoxycholate/Sulindac combination treatment effectively prevents intestinal adenomas in a mouse model of polyposis.
Academic Article
Aberrant crypt foci in the adenoma prevention with celecoxib trial.
Academic Article
The safety and efficacy of celecoxib in children with familial adenomatous polyposis.
Academic Article
Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention.
Academic Article
Improving the vision of colonoscopy: does the fine print really matter?
Academic Article
An international randomised trial of celecoxib versus celecoxib plus difluoromethylornithine in patients with familial adenomatous polyposis.
Academic Article
Immune Profiling of Premalignant Lesions in Patients With Lynch Syndrome.
Academic Article
Colorectal premalignancy is associated with consensus molecular subtypes 1 and 2.
Academic Article
Sulindac plus a phospholipid is effective for polyp reduction and safer than sulindac alone in a mouse model of colorectal cancer development.
Search Criteria
Polyps